Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts

Overview of attention for article published in Annals of Medicine, July 2009

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#17 of 1,665)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 30 news outlets
twitter: 3 X users

patent: 20 patents

Readers on

mendeley: 435 Mendeley

So far, Altmetric has seen 20 patents that reference this research output.

DRUG TREATMENT FOR MACULAR DEGENERATION

Application WO-2026136387-A1

World Intellectual Property Organisation (WIPO)

25 Jun 2026

APOE mimetic peptides and higher potency to clear plasma cholesterol

Grant US-RE50320-E1

United States of America

04 Mar 2025

COMPOSITION FOR USE IN TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION

Application EP-3950002-A1

European Patent Office

09 Feb 2022

ApoE mimetic peptides and higher potency to clear plasma cholesterol

Grant US-10653747-B2

United States of America

19 May 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 16 additional patents.